[Myocardial lesions induced by isoprenaline and their prevention by cinnarizine].
D000818:Animals; D002934:Cinnamates / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D007249:Inflammation / Q000139:chemically induced* / Q000517:prevention & control; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000008:administration & dosage; D009206:Myocardium / Q000473:pathology*; D009336:Necrosis / Q000139:chemically induced* / Q000517:prevention & control; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D002934:Cinnamates; D010879:Piperazines; D014665:Vasodilator Agents; D007545:Isoproterenol
Les lésions du myocarde proboquées par l'isoprénaline et leur prévention par la cinnarizine.